048530 — iNtRON Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩209bn
- KR₩152bn
- KR₩10bn
- 53
- 14
- 36
- 22
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3,188 | 14,948 | 9,728 | 5,712 | -9,695 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -890 | 20.6 | 2,283 | -4,382 | 6,792 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1,843 | -9,407 | 2,925 | 3,080 | 4,109 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -811 | 7,131 | 16,473 | 5,977 | 3,118 |
Capital Expenditures | -673 | -6,070 | -3,494 | -2,617 | -9,552 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -3,846 | 8,427 | -37,784 | -43,605 | 61,704 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -4,518 | 2,356 | -41,278 | -46,221 | 52,153 |
Financing Cash Flow Items | 1,156 | -56.6 | -0.014 | -0.01 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 37,315 | -2,066 | 39,750 | -9,191 | -40,168 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 32,032 | 6,514 | 15,243 | -49,359 | 15,175 |